LRIG1 inhibits STAT3-dependent inflammation to maintain corneal homeostasis

Journal of Clinical Investigation

Volumn 124, Issue 1, 2014, Pages 385-397

  Nakamura, Takahiro ^a,b   Hamuro, Junji ^a   Takaishi, Mikiro ^c   Simmons, Szandor ^d   Maruyama, Kazuichi ^a   Zaffalon, Andrea ^e   Bentley, Adam J ^f   Kawasaki, Satoshi ^a   Nagata Takaoka, Maho ^a   Fullwood, Nigel J ^f   Itami, Satoshi ^g   Sano, Shigetoshi ^c   Ishii, Masaru ^d   Barrandon, Yann ^e   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f LANCASTER UNIVERSITY   (United Kingdom)

^g OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; LEUCINE RICH REPEAT AND IMMUNOGLOBULIN LIKE DOMAIN 1; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL CELL; BLINDNESS; BONE MARROW; CELL FATE; CELL POPULATION; CHIMERA; CONTROLLED STUDY; CORNEA; CORNEA EPITHELIUM; CORNEA OPACITY; EPIDERMIS; EPITHELIUM CELL; GENE DELETION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY CELL; KERATINIZATION; KERATINOCYTE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; WOUND HEALING;

EID: 84892944262     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI71488     Document Type: Article

References (49)

1. Whitche JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79(3):214-221
2. Lavker RM, Sun TT. Epithelial stem cells: the eye provides a vision. Eye (Lond). 2003;17(8):937-942
3. De Luca M, Pellegrini G, Green H. Regeneration of squamous epithelia from stem cells of cultured grafts. Regen Med. 2006;1(1):45-57
4. Rama P, Matuska S, Paganoni G, Spinelli A, De Luca M, Pellegrini G. Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med. 2010; 363(2):147-155
5. Tan DT, Dart JK, Holland EJ, Kinoshita S. Corneal transplantation. Lancet. 2012;379(9827):1749-1761
6. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3(11):879-889
7. Blanpain C, Horsley V, Fuchs E. Epithelial stem cells: turning over new leaves. Cell. 2007;128(3):445-458
8. Li L, Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science. 2010; 327(5965):542-545
9. Schermer A, Galvin S, Sun TT. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol. 1986;103(1):49-62
10. Cotsarelis G, Cheng SZ, Dong G, Sun TT, Lavker RM. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 1989;57(2):201-209
11. Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci U S A. 1987;84(8):2302-2306
12. Pellegrini G, et al. Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol. 1999;145(4):769-782
13. Suzuki Y, et al. Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia. FEBS Lett. 2002;521(1-3):67-71
14. Jensen KB, Watt FM. Single-cell expression profiling of human epidermal stem and transit-Amplifying cells: Lrig1 is a regulator of stem cell quiescence. Proc Natl Acad Sci U S A. 2006;103(32):11958-11963
15. Jensen KB, et al. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell. 2009;4(5):427-439
16. Wong VW, et al. Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat Cell Biol. 2012;14(4):401-408
17. Powell AE, et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell. 2012;149(1):146-158
18. Majo F, Rochat A, Nicolas M, Jaoude GA, Barrandon Y. Oligopotent stem cells are distributed throughout the mammalian ocular surface. Nature. 2008;456(7219):250-254
19. Vauclair S, Majo F, Durham AD, Ghyselinck NB, Barrandon Y, Radtke F. Corneal epithelial cell fate is maintained during repair by Notch1 signaling via the regulation of vitamin A metabolism. Dev Cell. 2007;13(2):242-253
20. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2011; 12(1):21-27
21. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18(7):1028-1040
22. Bromberg J. Stat proteins and oncogenesis. J Clin Invest. 2002;109(9):1139-1142
23. Levy DE, Lee CK. What does Stat3 do? J Clin Invest. 2002;109(9):1143-1148
24. Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3(9):651-662
25. Chan KS, et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest. 2004; 114(5):720-728
26. Sano S, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med. 2005;11(1):43-49
27. Kovacic JC, et al. Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J Clin Invest. 2010;120(1):303-314
28. Shouda T, et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest. 2001;108(12):1781-1788
29. Yasukawa H, et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol. 2003;4(6):551-556
30. Wong PK, et al. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1- dependent inflammatory arthritis. J Clin Invest. 2006;116(6):1571-1581
31. Song H, Wang R, Wang S, Lin J. A low-molecular- weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci U S A. 2005; 102(13):4700-4705
32. Miyoshi K, et al. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol. 2011;131(1):108-117
33. Laederich MB, et al. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem. 2004; 279(45):47050-47056
34. Shattuck DL, et al. LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. Mol Cell Biol. 2007;27(5):1934-1946
35. Stutz MA, Shattuck DL, Laederich MB, Carraway KL 3rd, Sweeney C. LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII. Oncogene. 2008;27(43):5741-5752
36. Cursiefen C, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113(7):1040-1050
37. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest. 2007;117(5):1155-1166
38. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889-896
39. Matzinger P, Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol. 2011;11(3):221-230
40. Weidenbusch M, Anders HJ. Tissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis. J Innate Immun. 2012; 4(5-6):463-477
41. Goldszmid RS, Trinchieri G. The price of immunity. Nat Immunol. 2012;13(10):932-938
42. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013;229(2):176-185
43. Nakamura T, Endo K, Kinoshita S. Identification of human oral keratinocyte stem/progenitor cells by neurotrophin receptor p75 and the role of neurotrophin/ p75 signaling. Stem Cells. 2007;25(3):628-638
44. Nakamura T, et al. Hes1 regulates corneal development and the function of corneal epithelial stem/ progenitor cells. Stem Cells. 2008;26(5):1265-1274
45. Nakamura T, et al. The use of trehalose-treated freeze-dried amniotic membrane for ocular surface reconstruction. Biomaterials. 2008;29(27):3729-3737
46. Ueno M, et al. Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix. Proc Natl Acad Sci U S A. 2006; 103(25):9554-9559
47. Nakatsukasa M, et al. Tumor-Associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am J Pathol. 2010;177(3):1344-1355
48. Maruyama K, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005;115(9):2363-2372
49. Fukuhara S, et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J Clin Invest. 2012;122(4):1416-1426.